Our study suggests that sex difference should be considered as a critical factor to describe the underlying mechanism responsible for the improvement in glucose tolerance due to BAFF depletion, and gender-specific therapeutic application of BAFF inhibition could be a novel strategy for the treatment of type 2 diabetes. Here, TNFSF13B is linked to type 2 diabetes mellitus.